Thomas E. Mabry
Impact in
-
- Hepatitis C virus research
-
- Cholinesterase and Neurodegenerative Diseases
- Pharmacogenetics and Drug Metabolism
Papers in
-
- Cancer therapeutics and mechanisms 2
-
- Inflammatory mediators and NSAID effects 1
- Co-authors
- C. David Jones (4 shared papers)Joseph M. Colacino (2 shared papers)Kirk A. Staschke (1 shared paper)James E. Audia (4 shared papers)Bruce D. Gitter (3 shared papers)Jeffrey S. Nissen (3 shared papers)Mark H. Bender (3 shared papers)Patrick C. May (3 shared papers)
- Journals
- Neurobiology of Aging (3 papers)Journal of Medicinal Chemistry (2 papers)Antimicrobial Agents and Chemotherapy (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)
- Partner nations
- United States
In The Last Decade
Thomas E. Mabry
12 papers receiving 195 citations
Peers
Comparison fields: 5 of 49
- Hepatology 21
- Pharmacology 19
- Toxicology 7
- Pharmacology 33
- Physiology 49
Countries citing papers authored by Thomas E. Mabry
This map shows the geographic impact of Thomas E. Mabry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Thomas E. Mabry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Thomas E. Mabry more than expected).
Fields of papers citing papers by Thomas E. Mabry
This network shows the impact of papers produced by Thomas E. Mabry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Thomas E. Mabry. The network helps show where Thomas E. Mabry may publish in the future.
Co-authors
The 25 scholars most cited alongside Thomas E. Mabry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1994 | 35 | |
| 2 | 2014 | 28 | |
| 3 | 1992 | 25 | |
| 4 | 2004 | 24 | |
| 5 | 1994 | 20 | |
| 6 | 2002 | 19 | |
| 7 | 1994 | 15 | |
| 8 | 2004 | 13 | |
| 9 | 2004 | 12 | |
| 10 | 2017 | 4 | |
| 11 | 2017 | 2 | |
| 12 | 1991 | 2 |
About Thomas E. Mabry
Thomas E. Mabry is a scholar working on Molecular Biology, Pharmacology, Oncology, Organic Chemistry and Surgery, having authored 12 papers that have together received 199 indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (2 papers), Estrogen and related hormone effects (2 papers), Cancer therapeutics and mechanisms (2 papers), Computational Drug Discovery Methods (2 papers), Pneumocystis jirovecii pneumonia detection and treatment (1 paper), Click Chemistry and Applications (1 paper), Inflammatory mediators and NSAID effects (1 paper) and Hepatitis B Virus Studies (1 paper). The work is most often cited by research in Hepatology (21 citations), Pharmacology (19 citations), Toxicology (7 citations), Pharmacology (33 citations) and Physiology (49 citations). Thomas E. Mabry has collaborated with scholars based in United States. Frequent co-authors include C. David Jones, Joseph M. Colacino, Kirk A. Staschke, James E. Audia, Bruce D. Gitter, Jeffrey S. Nissen, Mark H. Bender, Patrick C. May, Paul A. Hyslop and Larry C. Blaszczak. Their work appears in journals such as Neurobiology of Aging, Journal of Medicinal Chemistry, Antimicrobial Agents and Chemotherapy, Bioorganic & Medicinal Chemistry Letters and Journal of Pharmacology and Experimental Therapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.